Intelligent Bio Solutions (INBS) Liabilities and Shareholders Equity (2020 - 2025)

Intelligent Bio Solutions' Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $8.2 million for Q2 2025.

• In Q2 2025, Liabilities and Shareholders Equity fell 40.13% year-over-year to $8.2 million; the TTM figure through Jun 2025 stood at $38.2 million (down 20.89% YoY), while the FY2025 annual figure was $8.2 million, down 40.13% from the prior year.
• Liabilities and Shareholders Equity was $8.2 million for Q2 2025 at Intelligent Bio Solutions, down from $9.6 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $21.9 million in Q2 2021 to a low of $8.2 million in Q2 2025.
• Historically, Liabilities and Shareholders Equity has averaged $13.1 million across 5 years, with a median of $12.0 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Liabilities and Shareholders Equity soared 782.98% in 2021, then plunged 51.09% in 2023.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $15.2 million in 2021, then climbed by 18.46% to $18.0 million in 2022, then slumped by 51.09% to $8.8 million in 2023, then retreated by 1.62% to $8.7 million in 2024, then declined by 5.0% to $8.2 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $8.2 million (Q2 2025), $9.6 million (Q1 2025), and $8.7 million (Q4 2024), per Business Quant data.